Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in adrenomyeloneuropathy
2011-006113-34Phase 2Completed
- Sponsor
- AURORA PUJOL ONOFRE
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pioglitazone in adrenomyeloneuropathy (AMN) and adrenoleukodystrophy (ALD), sponsored by AURORA PUJOL ONOFRE. Primary endpoint: Change in 6-minute walk test distance from baseline to month 24. Started Sep 2013; status: completed.
02
Drugs
pioglitazone
03
Conditions
adrenomyeloneuropathy (AMN)adrenoleukodystrophy (ALD)
Beyond the preview
Go deeper on 2011-006113-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006113-34.